Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.
about
Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia (ALL) in first complete remissionAutologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemiaAllogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remissionAutologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemiaFludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemiaImaging findings in recurrent extramedullary leukaemias.Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia.NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell TrResults of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemiaClinical applications of BCR-ABL molecular testing in acute leukemiaEmerging drugs for adult acute lymphoblastic leukaemia.Autologous stem cell transplant in ALL: who should we be transplanting in first remission?Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.Cellular therapies in acute lymphoblastic leukemiaOutcomes of a modified CALGB 19802 regimen in adult acute lymphoblastic leukemia.Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.Allogeneic hematopoietic cell transplantation for adults with ALL.Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years.Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study.Therapy of Philadelphia chromosome-negative acute lymphoblastic leukemia in adults: new paradigms.Philadelphia chromosome-positive acute lymphoblastic leukemia.Current treatment options for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.Treatment of acute lymphoblastic leukemia in adolescents and young adults.Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia.Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults.Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL).Adoptive immunotherapy for B-cell malignancies with autologous chimeric antigen receptor modified tumor targeted T cells.Cellular therapies in acute lymphoblastic leukemia.Outcome of adults with acute lymphocytic leukemia in second or subsequent complete remission.Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration.Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimenAutologous Hematopoietic Stem Cell Transplantation for High-risk Acute Lymphoblastic Leukemia: non-Randomized Study with a maximum Follow-up of more than 22 Years.Outcome of adults with acute lymphocytic leukemia after second salvage therapy.Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.Redefining transplant in acute leukemia.Long-term outcome of ph-negative acute lymphoblastic leukaemia in adults: a single centre experience.The superiority of allogeneic hematopoietic stem cell transplantation from unrelated donor over chemotherapy for adult patients with high-risk acute lymphoblastic leukemia in first remission.The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparison.
P2860
Q24234305-F5D8185B-A799-45AC-9971-CF8E04341635Q24235485-CBF1A21F-3BA6-47C4-AA96-917667A41B81Q24235952-9BAE4539-A2CA-450A-A0F8-90CE26C262D2Q24242466-471C71BF-A2CC-4C16-A080-F8F00C0B7B9BQ30276948-78BEFC96-9159-4476-9963-C495FC8701C2Q30436744-73576818-EB14-4F09-838B-CE8D10734C57Q33747668-444AE8DC-E166-4B94-8CA9-8FB6A153FE80Q34044024-9E3E6850-B108-441B-8DCB-C9C6A93951C5Q34350665-14EA13F9-1050-435D-A18B-125F8EEE8885Q35111716-C73B92FD-4188-4244-806F-E300030CF599Q36219661-5DECA514-0EB9-4ED3-8D72-D97462CE99BEQ36457738-7A860712-3CA9-4387-83B9-F8EB610769B2Q36477219-B8B96FDF-6353-4E55-88AA-8B43BC4BAC44Q36552098-4EE4CF62-1113-4780-81BF-5EF0B6941FABQ36854190-A5926EB1-B2D2-4D44-84B3-075F1C04A5E6Q36984856-B7B46C1D-4A14-4EFE-B6E7-82CC359ADD6EQ37251043-65968852-5580-4466-A5FA-A3F3E4AE6198Q37271941-304B0162-57D9-4A46-88C5-B14B165C09BFQ37522294-C15E95D0-3A92-4D78-9D9B-69CD21ED03DBQ37605864-E6106CBA-EEE6-4C2D-A315-81A104B9140AQ37613888-9FDF3291-3EEC-4C7A-A653-E8C7A86B7F76Q37650203-BF0E936D-B7B6-46CE-A9A2-62D44E9B73B2Q37659142-4D5CD0E5-95FD-45B4-A7D7-981AA37F061CQ37899785-F4FF9EB7-6941-4F60-9AD2-7C1C7225961BQ38451661-D8DC1B8C-445D-4E99-8AB5-512B57C175AAQ38777538-995B506C-17C7-4518-B9D4-0DAC1AE048F8Q41363547-489A6D62-5CAC-48F6-8A6A-47183848FE32Q41438622-103D9A65-A1D4-4704-8E33-5124CF12DB13Q41560177-157794E5-DCB8-4C1B-BE8F-98B2211DFB9CQ42088239-E441EFCA-3AF3-4B72-8F3B-A3D4B7DDF61FQ42223690-BAB1E489-1E1D-48E2-AAD1-E826C44FEAC9Q42634946-5B84BFDE-A219-40C3-BB46-CDBB4A837B28Q42739686-9F26CA26-C8A3-4720-86A0-0BDD75CFBBF6Q42933654-EFFC1C12-ADDA-4214-83E6-5D59D9E5AE4CQ44250679-A09753DE-89B9-4E71-9AEF-24D9106A0885Q44657508-4EBC7149-27A3-4BF4-BD43-D619FD189C94Q46570858-71803125-C81F-44E6-874D-BFBC54C72CEBQ46639944-70260593-5FD6-4681-8256-EF68B124F990Q47304820-091D4A5C-7D1E-4949-ADEC-361F8FE67B65
P2860
Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Adult acute lymphocytic leukem ...... f the French protocol LALA 87.
@ast
Adult acute lymphocytic leukem ...... f the French protocol LALA 87.
@en
Adult acute lymphocytic leukem ...... f the French protocol LALA 87.
@nl
type
label
Adult acute lymphocytic leukem ...... f the French protocol LALA 87.
@ast
Adult acute lymphocytic leukem ...... f the French protocol LALA 87.
@en
Adult acute lymphocytic leukem ...... f the French protocol LALA 87.
@nl
prefLabel
Adult acute lymphocytic leukem ...... f the French protocol LALA 87.
@ast
Adult acute lymphocytic leukem ...... f the French protocol LALA 87.
@en
Adult acute lymphocytic leukem ...... f the French protocol LALA 87.
@nl
P2093
P921
P1476
Adult acute lymphocytic leukem ...... f the French protocol LALA 87.
@en
P2093
Reiffers J
Thiebaut A
Vernant JP
P304
1353-66, x
P356
10.1016/S0889-8588(05)70190-8
P577
2000-12-01T00:00:00Z